Protein Rejuvenates Aged Cells and Extends Mouse Lifespan
The SRSF1 protein offers a potential new target for cellular aging research that maintains tissue identity.
Updated on Oct. 21, 2026 in Life Sciences
Live Poll
Should scientists prioritize gene-based interventions designed to extend human lifespan?
Researchers have identified an RNA-splicing protein called SRSF1 that rejuvenates aged cells without inducing the loss of cellular identity seen in other techniques. The study, published in Nature Aging, demonstrates that targeted expression of this protein reverses signs of aging in human skin cells and extends the median lifespan of mice by 14 percent.
Why it matters
Current approaches to cellular rejuvenation, such as partial reprogramming, often risk abnormal cell proliferation or loss of cellular identity. By targeting SRSF1, researchers are exploring a potential pathway to stabilize cellular aging while maintaining the specialized function of tissues.
SRSF1 treatment in human fibroblasts demonstrated an estimated average age reversal of 26 years, alongside a 25% increase in collagen production and a 30% reduction in reactive oxygen species compared to untreated baseline cells.
The players
Wyss Institute
A research center at Harvard University specializing in biologically inspired engineering and synthetic biology.
CIC bioGUNE
A Spanish research organization focused on structural biology, molecular medicine, and cellular research.
The details
The team utilized transcriptomic profiles from individuals aged one to 96 to train a machine learning model incorporating 146 genes to quantify cellular age. To test the effect of SRSF1, they employed an adeno-associated viral vector—a modified, non-pathogenic virus used for gene delivery—to increase protein expression in the liver of mice. While this process improved tissue health, previous experimental settings have linked SRSF1 overexpression to tumor-promoting effects, necessitating further investigation into safety thresholds.
Timeline
October 20, 2026: The findings were published in Nature Aging.
The Tech Race
This research positions itself against the broader field of cellular reprogramming, which aims to reset the epigenetic clock of cells. By focusing on SRSF1, the authors seek to overcome the current limitations of established protocols that often suffer from proliferative side effects.
This development is currently in the research stage and remains limited to laboratory models in mice and cell cultures. Future clinical applications depend on researchers successfully demonstrating safe expression levels that avoid the tumor-promoting effects previously associated with this protein.
The takeaway
The study validates a new molecular target that could potentially address age-related decline without the risks inherent in current epigenetic reprogramming. Readers should watch for follow-up research specifically investigating the long-term safety profile and tumor-promoting potential of SRSF1 expression.
Further reading
For broader context on cellular aging research, explore the latest findings in Life Sciences.
Source note: This article includes information reported by Drug Discovery News.
Live Poll
Should scientists prioritize gene-based interventions designed to extend human lifespan?
